Skip to main content
Journal cover image

MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES

Publication ,  Conference
Cohen, K; Chi, S; Hawkins, C; Rodriguez, F; London, W; Castellino, RC; Aguilera, D; Stapleton, S; Ashley, D; Landi, D; Bandopadhayay, P
Published in: Neuro-Oncology
December 4, 2020

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

December 4, 2020

Volume

22

Issue

Supplement_3

Start / End Page

iii393 / iii394

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cohen, K., Chi, S., Hawkins, C., Rodriguez, F., London, W., Castellino, R. C., … Bandopadhayay, P. (2020). MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES. In Neuro-Oncology (Vol. 22, pp. iii393–iii394). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaa222.501
Cohen, Kenneth, Susan Chi, Cynthia Hawkins, Fausto Rodriguez, Wendy London, Robert Craig Castellino, Dolly Aguilera, et al. “MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES.” In Neuro-Oncology, 22:iii393–94. Oxford University Press (OUP), 2020. https://doi.org/10.1093/neuonc/noaa222.501.
Cohen K, Chi S, Hawkins C, Rodriguez F, London W, Castellino RC, et al. MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES. In: Neuro-Oncology. Oxford University Press (OUP); 2020. p. iii393–4.
Cohen, Kenneth, et al. “MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES.” Neuro-Oncology, vol. 22, no. Supplement_3, Oxford University Press (OUP), 2020, pp. iii393–94. Crossref, doi:10.1093/neuonc/noaa222.501.
Cohen K, Chi S, Hawkins C, Rodriguez F, London W, Castellino RC, Aguilera D, Stapleton S, Ashley D, Landi D, Bandopadhayay P. MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES. Neuro-Oncology. Oxford University Press (OUP); 2020. p. iii393–iii394.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

December 4, 2020

Volume

22

Issue

Supplement_3

Start / End Page

iii393 / iii394

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences